Use access key #2 to skip to page content.
$35.08 -0.33 (-0.93%)
10/10/2008 4:04 PM

GlaxoSmithKline plc (ADR) (GSK)

CAPS Rating:
*****

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

View All Commentary (GSK)

Recs

3

Avatar TMFArkle (96.69) Submitted: 8/13/06 6:48 PM : Outperform Start Price: $51.10 GSK Score: -0.64

This is a quality pharma giant. CEO JP Garnier has done great work improving the R&D productivity, and the company looks set to be a great long-term winner. Not a bargain basement price, but quality is worth paying for. Only real downside is concerns that govts, including the US, will keep driving drugs prices down.

Report this Post Replies: 1 | Reply

Avatar bobbydove (< 20) Submitted: 12/14/06 6:01 PM

Recs: 0 | Rec This

if our good friends at thestreet.com are correct, we'll be looking at a 26% gain within a year. with a 3.4% dividend while we wait? i like the stock AND the price!

Report this Post Reply

Featured Broker Partners